Pediatrix Medical Group Management
Management criteria checks 1/4
Pediatrix Medical Group's CEO is Mark Ordan, appointed in Jan 2025, has a tenure of less than a year. directly owns 0.16% of the company’s shares, worth MX$38.22M. The average tenure of the management team and the board of directors is 1.6 years and 4.8 years respectively.
Key information
Mark Ordan
Chief executive officer
US$1.1m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 0.2% |
| Management average tenure | 1.6yrs |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2025 | n/a | n/a | -US$82m |
| Dec 31 2024 | US$1m | n/a | -US$99m |
| Sep 30 2024 | n/a | n/a | -US$254m |
| Jun 30 2024 | n/a | n/a | -US$252m |
| Mar 31 2024 | n/a | n/a | -US$71m |
| Dec 31 2023 | US$554k | n/a | -US$60m |
| Sep 30 2023 | n/a | n/a | US$88m |
| Jun 30 2023 | n/a | n/a | US$95m |
| Mar 31 2023 | n/a | n/a | US$98m |
| Dec 31 2022 | US$5m | US$1m | US$63m |
| Sep 30 2022 | n/a | n/a | US$79m |
| Jun 30 2022 | n/a | n/a | US$82m |
| Mar 31 2022 | n/a | n/a | US$82m |
| Dec 31 2021 | US$7m | US$1m | US$108m |
| Sep 30 2021 | n/a | n/a | US$72m |
| Jun 30 2021 | n/a | n/a | US$38m |
| Mar 31 2021 | n/a | n/a | US$14m |
| Dec 31 2020 | US$6m | US$471k | -US$10m |
Compensation vs Market: Mark's total compensation ($USD1.13M) is above average for companies of similar size in the MX market ($USD647.56K).
Compensation vs Earnings: Mark's compensation has increased whilst the company is unprofitable.
CEO
Mark Ordan (65 yo)
less than a year
Tenure
US$1,130,001
Compensation
Mr. Mark S. Ordan is Director of Harris Teeter Supermarkets, Inc. from February 2013. He joined the Harris Teeter Supermarkets, Inc. in February 2013. He is Director of Oakleaf Waste Management, LLC.He is...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Chairman | less than a year | US$1.13m | 0.16% MX$ 38.2m | |
| Executive VP | less than a year | US$1.34m | 0.086% MX$ 20.9m | |
| Chief Administrative Officer | 2.6yrs | US$2.39m | 0.29% MX$ 70.7m | |
| Senior Vice President of Operations | no data | no data | no data | |
| Senior VP & Chief Accounting Officer | 9yrs | US$1.43m | no data | |
| Senior VP & Chief Information Officer | 3.3yrs | no data | no data | |
| Senior Vice President of People Services | less than a year | no data | no data | |
| Senior Vice President of Administration & Managed Care | no data | no data | no data | |
| President of West Division | less than a year | no data | no data | |
| President of South Central Division | no data | no data | no data | |
| Chief Medical Officer of South Central Division | no data | no data | no data | |
| Senior Vice President of Medical Administrative Services | 3yrs | no data | no data |
1.6yrs
Average Tenure
62yo
Average Age
Experienced Management: MD *'s management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Chairman | 4.8yrs | US$1.13m | 0.16% MX$ 38.2m | |
| Lead Independent Director | 4.8yrs | US$280.00k | 0.095% MX$ 23.2m | |
| Independent Director | 4.8yrs | US$252.50k | 0.079% MX$ 19.2m | |
| Independent Director | 2yrs | US$230.00k | 0.048% MX$ 11.8m | |
| Independent Director | 4.8yrs | US$230.00k | 0.079% MX$ 19.2m | |
| Independent Director | 4.8yrs | US$245.00k | 0.056% MX$ 13.8m | |
| Board Observer | 4.8yrs | no data | no data | |
| Independent Director | 6yrs | US$242.50k | 0.083% MX$ 20.2m | |
| Independent Director | 3yrs | US$230.00k | 0.015% MX$ 3.6m |
4.8yrs
Average Tenure
60yo
Average Age
Experienced Board: MD *'s board of directors are considered experienced (4.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/18 09:49 |
| End of Day Share Price | 2025/05/13 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Pediatrix Medical Group, Inc. is covered by 32 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Toung | Argus Research Company |
| Matthew Gillmor | Baird |
| James Kumpel | BB&T Capital Markets |